Tango Therapeutics TNGX Income Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $2.18M+34.9% | $1.68M-7.3% | $1.1M-39.4% | $1.24M-40.2% | $1.61M-26.5% | ||
| $0-100% | $0-100% | $53.81M+364% | $3.18M-84.0% | $5.39M-16.7% | ||
| $33.53M-8.0% | $32.1M-5.4% | $30.82M-7.4% | $32.81M-15.1% | $36.44M-4.3% | ||
| $48.77M+1.8% | $41.86M-7.0% | $39.74M-10.7% | $44.15M-10.7% | $47.92M-1.7% | ||
| $48.77M+1.8% | $41.86M-7.0% | $39.74M-10.7% | $44.15M-10.7% | $47.92M-1.7% | ||
| $3.26M+21.1% | $3.06M-7.0% | $1.8M-52.1% | $2.15M-47.1% | $2.69M-38.6% | ||
| -$45.51M-14.1% | -$38.75M-2.9% | $15.88M+154% | -$38.85M-52.1% | -$39.88M-5.2% | ||
| -$0.32+11.1% | -$0.30+11.8% | $0.14+152% | -$0.35-45.8% | -$0.36-2.9% | ||
| 143.6M+30.2% | 116.2M+6.4% | 111M+2.3% | 110.5M+2.1% | 110.3M+2.0% | ||
| -$45.85M-14.6% | -$38.65M-1.5% | $15.91M+157% | -$38.95M-52.0% | -$40.02M-4.3% | ||
| $2.18M+34.9% | $1.68M-7.3% | $1.1M-39.4% | $1.24M-40.2% | $1.61M-26.5% | ||
| $79.85M+3,992,200% | $219.38M+22,539% | $2.54M+5.8% | $581K-55.7% | $2K-100.0% | ||
| $9.64M-68.5% | -$135.72M-361% | $47.48M+45.8% | $16.78M+32.1% | $30.6M+373% | ||
| -$44.36M-6.4% | -$29.72M+18.9% | -$30.95M+7.3% | -$36.52M-54.7% | -$41.7M-10.1% | ||
| $1.08M+0.5% | $1.38M-6.5% | $705K-64.0% | $910K-54.4% | $1.07M-50.8% | ||
| $537K+5,867% | $9K— | $9K— | $9K— | $9K— | ||
| -$48.31M-15.3% | -$41.39M-2.7% | $14.63M+145% | -$40.34M-39.5% | -$41.91M-0.7% | ||
| -$48.77M-14.7% | -$41.86M-2.3% | $14.07M+143% | -$40.97M-38.6% | -$42.53M-0.7% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Where does Tango Therapeutics's income statement data come from?
- Every line is extracted from Tango Therapeutics's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.